Clonal architecture of chronic myelomonocytic leukemias.

Abstract : Genomic studies in chronic myeloid malignancies, including myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), and MPN/MDS, have identified common mutations in genes encoding signaling, epigenetic, transcription, and splicing factors. In the present study, we interrogated the clonal architecture by mutation-specific discrimination analysis of single-cell-derived colonies in 28 patients with chronic myelomonocytic leukemias (CMML), the most frequent MPN/MDS. This analysis reveals a linear acquisition of the studied mutations with limited branching through loss of heterozygosity. Serial analysis of untreated and treated samples demonstrates a dynamic architecture on which most current therapeutic approaches have limited effects. The main disease characteristics are early clonal dominance, arising at the CD34(+)/CD38(-) stage of hematopoiesis, and granulomonocytic differentiation skewing of multipotent and common myeloid progenitors. Comparison of clonal expansions of TET2 mutations in MDS, MPN, and CMML, together with functional invalidation of TET2 in sorted progenitors, suggests a causative link between early clonal dominance and skewed granulomonocytic differentiation. Altogether, early clonal dominance may distinguish CMML from other chronic myeloid neoplasms with similar gene mutations.
Type de document :
Article dans une revue
Blood, American Society of Hematology, 2013, 121 (12), pp.2186-98. 〈10.1182/blood-2012-06-440347〉
Liste complète des métadonnées
Contributeur : Laurence Sauboy <>
Soumis le : jeudi 2 janvier 2014 - 12:59:13
Dernière modification le : mardi 26 février 2019 - 10:12:33

Lien texte intégral



Raphaël Itzykson, Olivier Kosmider, Aline Renneville, Margot Morabito, Claude Preudhomme, et al.. Clonal architecture of chronic myelomonocytic leukemias.. Blood, American Society of Hematology, 2013, 121 (12), pp.2186-98. 〈10.1182/blood-2012-06-440347〉. 〈hal-00923316〉



Consultations de la notice